Aug. 19th, 2011

Everything’s coming up noses for Intersect ENT

Surgery blows—especially when your schnoz is involved. But with the FDA’s recent approval of their new product Propel™, our client Intersect ENT is poised to revolutionize chronic sinusitis treatment for good. 

Unlike anything in its category, Propel is a spring-like device made of a flexible, lightweight plastic polymer. This innovative design serves to gently prop open the sinuses after endoscopic surgery. The device also delivers an anti-inflammatory corticosteroid directly to the sinus lining, which keeps patients’ noses from flaring up like a bull seeing red. The result? Improved post-surgical outcomes, and reduced need for oral steroids that can have nasty side effects. It’s genius, really.

Inspired by Propel’s iconic design, Mortar created a distinctive logo to establish the brand identity for our client’s inaugural product. Evoking the shape and warmth of the sun, the mark quickly conveys the elegant nature of the device. See?

Screen shot 2011-08-19 at 11.45.26 AM

There’s also a website on the way, and we designed a trade show booth for Propel’s debut at the American Academy of Otolaryngology’s convention this September in San Francisco. If you’re in town, stop in and rub elbows. Or noses. 


  • May. 16th, 2012

    […] We explained the beauty of PROPEL before, and it’s worth a refresher course. In the sinusitis arena, there’s no solution as cleverly designed and multi-functional as PROPEL, which is why it’s such a big deal. […]

Post a Comment